• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    NABP Announces Walgreens Joining Pulse Platform

    9/10/24 12:00:00 PM ET
    $WBA
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples
    Get the next $WBA alert in real time by email

    MOUNT PROSPECT, Ill., Sept. 10, 2024 /PRNewswire/ -- Walgreens has joined Pulse by NABP™, the new digital platform from National Association of Boards of Pharmacy® (NABP®) that will bring visibility to the drug supply chain and protect patients from counterfeit or substandard prescription medications. Walgreens will use Pulse to assist with Drug Supply Chain Security Act (DSCSA) compliance and to help ensure its prescription medication suppliers are appropriately licensed.

    National Association of Boards of Pharmacy Logo (PRNewsfoto/National Association of Boards of Pharmacy)

    Walgreens will use Pulse to assist with DSCSA compliance and protect patients from counterfeit prescription medications.

    DSCSA is a federal law that was enacted in 2013 to improve the safety of the pharmaceutical supply chain and to help prevent harmful drugs from entering the market. The law requires all members of the pharmaceutical supply chain to ensure they are doing business with trading partners that are authorized in accordance with federal law.

    Pulse will help ensure that only legitimate and authorized trading partners can provide medications to Walgreens' patients.

    "Walgreens is committed to protecting the health and safety of our patients," said John Colaizzi, PharmD, FNJPhA, vice president of pharmacy practice at Walgreens. "Joining Pulse will be an additional DSCSA compliance tool that will help Walgreens ensure that the medications our patients take are legitimate."

    "We are pleased to welcome Walgreens to Pulse," said Lemrey "Al" Carter, PharmD, MS, RPh, executive director/secretary of NABP. "Walgreens' participation in Pulse will help to strengthen the security of the pharmaceutical supply chain and help protect Walgreens' patients."

    NABP is rolling out the Pulse platform to certain users in the supply chain. After this initial onboarding, NABP will provide free registration on the Pulse platform for any member of the prescription drug supply chain to facilitate interoperability, as required by DSCSA.

    Learn more about Pulse and DSCSA compliance at https://pulse.pharmacy.

    About NABP

    NABP is the independent, international, and impartial 501(c)(3) nonprofit Association that assists its state member boards and jurisdictions in protecting the public health. NABP was established in 1904 to assist the state boards of pharmacy in creating uniform education and licensure standards. Today, we help support patient and prescription drug safety through examinations that assess pharmacist competency, pharmacist licensure transfer and verification services, and various pharmacy accreditation and inspection programs.

    About Walgreens

    Walgreens (www.walgreens.com) is included in the U.S. Retail Pharmacy and U.S. Healthcare segments of Walgreens Boots Alliance, Inc. (NASDAQ:WBA), an integrated healthcare, pharmacy and retail leader. True to its purpose of "more joyful lives through better health," Walgreens has a more than 120-year heritage of caring for communities and providing trusted pharmacy services, and today is playing a greater role as an independent partner of choice offering healthcare services that improve care, lower costs, and help patients. Operating nearly 9,000 retail locations across the U.S. and Puerto Rico, Walgreens is proud to serve nearly 9 million customers and patients daily. The company's pharmacists are playing a more critical role in healthcare than ever before, providing a wide range of pharmacy and healthcare services, including those that drive equitable access to care for some of the nation's most underserved populations. Walgreens offers customers and patients a true omnichannel experience, with fully integrated physical and digital platforms designed to deliver high-quality products and healthcare services. Within the U.S. Healthcare segment, Walgreens portfolio also includes businesses in primary care, multi-specialty, post-acute care, urgent care, specialty pharmacy services, population health and provider enablement.

    Media Contact: [email protected]

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/nabp-announces-walgreens-joining-pulse-platform-302243834.html

    SOURCE National Association of Boards of Pharmacy

    Get the next $WBA alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $WBA

    DatePrice TargetRatingAnalyst
    2/28/2025$11.00 → $9.00Hold → Sell
    Deutsche Bank
    2/26/2024$23.00Market Perform
    Leerink Partners
    2/20/2024Hold → Reduce
    HSBC Securities
    1/3/2024$21.00Underweight
    Barclays
    12/22/2023$27.00Hold
    HSBC Securities
    10/23/2023$27.00 → $30.00Neutral → Overweight
    JP Morgan
    7/3/2023$37.00 → $27.00Underweight
    Morgan Stanley
    6/28/2023$46.00 → $34.00Buy → Hold
    Deutsche Bank
    More analyst ratings